| Date | Name | Shares | Transaction | Value |
|
Nov 17, 2025
| David John Mastrocola Director |
18,115
| Open market or private purchase of non-derivative security Non-derivative transaction at $29.05 per share |
526,240.75
|
|
May 20, 2025
| Richard Joseph Freeland Director |
7,527
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
May 20, 2025
| Stephen A. van Oss Director |
7,527
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
May 20, 2025
| Robert Joseph Remenar Director |
7,527
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
May 20, 2025
| John G. Boss Director |
79,338
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
May 20, 2025
| John G. Boss Director |
7,527
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
May 20, 2025
| John G. Boss Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
May 20, 2025
| Sonya F. Sepahban Director |
7,527
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
May 20, 2025
| Christine M. Moore Director |
41,296
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
May 20, 2025
| Christine M. Moore Director |
7,527
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
May 20, 2025
| Christine M. Moore Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
May 20, 2025
| Adriana E. Macouzet-Flores Director |
50,845
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
May 20, 2025
| Adriana E. Macouzet-Flores Director |
50,515
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $24.3 per share |
1,227,514.50
|
|
May 20, 2025
| Adriana E. Macouzet-Flores Director |
7,527
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
May 20, 2025
| Adriana E. Macouzet-Flores Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Feb 26, 2025
| Jonathan P. Banas EVP and CFO |
38,513
| Open market or private purchase of non-derivative security Non-derivative transaction at $15 per share |
577,695.00
|